Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jun;24(1):1-13.
doi: 10.1385/ENDO:24:1:001.

Hypothyroidism as a risk factor for cardiovascular disease

Affiliations
Review

Hypothyroidism as a risk factor for cardiovascular disease

Bernadette Biondi et al. Endocrine. 2004 Jun.

Abstract

The cardiovascular risk in patients with hypothyroidism is related to an increased risk of functional cardiovascular abnormalities and to an increased risk of atherosclerosis. The pattern of cardiovascular abnormalities is similar in subclinical and overt hypothyroidism, suggesting that a lesser degree of thyroid hormone deficiency may also affect the cardiovascular system. Hypothyroid patients, even those with subclinical hypothyroidism, have impaired endothelial function, normal/depressed systolic function, left ventricular diastolic dysfunction at rest, and systolic and diastolic dysfunction on effort, which may result in poor physical exercise capacity. There is also a tendency to increase diastolic blood pressure as a result of increased systemic vascular resistance. All these abnormalities regress with L-T4 replacement therapy. An increased risk for atherosclerosis is supported by autopsy and epidemiological studies in patients with thyroid hormone deficiency. The "traditional" risk factors are hypertension in conjunction with an atherogenic lipid profile; the latter is more often observed in patients with TSH >10 mU/L. More recently, C-reactive protein, homocysteine, increased arterial stiffness, endothelial dysfunction, and altered coagulation parameters have been recognized as risk factors for atherosclerosis in patients with thyroid hormone deficiency. This constellation of reversible cardiovascular abnormalities in patient with TSH levels <10 mU/L indicate that the benefits of treatment of mild thyroid failure with appropriate doses of L-thyroxine outweigh the risk.

PubMed Disclaimer

References

    1. Thyroid. 1996 Oct;6(5):505-12 - PubMed
    1. Atherosclerosis. 1987 Nov;68(1-2):51-8 - PubMed
    1. Clin Endocrinol (Oxf). 1988 Jul;29(1):63-75 - PubMed
    1. Clin Endocrinol (Oxf). 2001 Feb;54(2):197-204 - PubMed
    1. Circulation. 1997 Oct 21;96(8):2542-4 - PubMed

MeSH terms